Search research articles
Contact Us
Filters
Showing results (351-360 of 363) with videos related to
Page
of 37
Sort By:
Global Change Biology
|
March 19, 2013
Methane indicator values for peatlands: a comparison of species and functional groups
Alan Gray, Peter E Levy, Mark D A Cooper, et al.
The Journal of Infectious Diseases
|
August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data
J P Ioannidis, A C Collier, D A Cooper, et al.
Human Vaccines
|
October 3, 2006
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects
S Emery, C Workman, R L Puls, et al.
The New England Journal of Medicine
|
October 16, 2009
Interleukin-2 therapy in patients with HIV infection
, , D Abrams, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer Cells
K S Young, G R Hancock, E Fink, et al.
The Journal of Infectious Diseases
|
June 1, 1996
Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group
R T Schooley, C Ramirez-Ronda, J M Lange, et al.
Research Square
|
July 9, 2024
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer Cells
K S Young, G R Hancock, E Fink, et al.
HIV Medicine
|
February 20, 2007
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database
J Zhou, N I Paton, R Ditangco, et al.
Breast Cancer Research : BCR
|
January 17, 2025
Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells
K S Young, G R Hancock, E C Fink, et al.
International Journal of Antimicrobial Agents
|
March 13, 1999
Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial
A M Been-Tiktak, C A Boucher, F Brun-Vezinet, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 363) with videos related to
Sort By:
Page
of 37
Global Change Biology
|
March 19, 2013
Methane indicator values for peatlands: a comparison of species and functional groups
Alan Gray, Peter E Levy, Mark D A Cooper, et al.
The Journal of Infectious Diseases
|
August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data
J P Ioannidis, A C Collier, D A Cooper, et al.
Human Vaccines
|
October 3, 2006
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects
S Emery, C Workman, R L Puls, et al.
The New England Journal of Medicine
|
October 16, 2009
Interleukin-2 therapy in patients with HIV infection
, , D Abrams, et al.
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer Cells
K S Young, G R Hancock, E Fink, et al.
The Journal of Infectious Diseases
|
June 1, 1996
Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group
R T Schooley, C Ramirez-Ronda, J M Lange, et al.
Research Square
|
July 9, 2024
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer Cells
K S Young, G R Hancock, E Fink, et al.
HIV Medicine
|
February 20, 2007
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database
J Zhou, N I Paton, R Ditangco, et al.
Breast Cancer Research : BCR
|
January 17, 2025
Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells
K S Young, G R Hancock, E C Fink, et al.
International Journal of Antimicrobial Agents
|
March 13, 1999
Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial
A M Been-Tiktak, C A Boucher, F Brun-Vezinet, et al.
Page
of 37